Catalyst Wire Dossier Catalyst Wire Dossier

insulin lispro (hepatic-directed vesicle encapsulated)

insulin lispro · Diasome Pharmaceuticals
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for insulin lispro (hepatic-directed vesicle encapsulated), covering 2020-04-02 to 2020-04-02. Get the full timeline:

Most recent: Clinical Trial Update: Comparison of Different Insulin Dosing Algorithms Using Hepatic Directed Vesicle-Insulin Lispro and Insulin Degludec [Phase 2]

See pricing